Blockchain Registration Transaction Record

Izotropic Secures Exclusive AI Breast CT Patent, Revolutionizing Cancer Detection

Izotropic Corporation secures exclusive U.S. patent for AI-enhanced breast CT CADx technology through University of California license, revolutionizing cancer detection.

This development matters because breast cancer remains one of the most common cancers affecting women worldwide, with early detection being critical for survival rates. The integration of AI-powered computer-aided diagnosis specifically designed for breast CT imaging could significantly improve detection accuracy, particularly for the 40-50% of women with dense breast tissue where traditional mammograms often miss cancers. This technology has the potential to reduce false negatives, enable earlier intervention, and ultimately save lives while creating a new standard of care in breast cancer screening. For healthcare systems, it represents a step toward more efficient and accurate diagnostic workflows that could reduce unnecessary biopsies and follow-up procedures.